Brain tumours
C19 – C27
- C19: Prognostic significance of MGMT promoter methylation in glioblastomas treated with temozolomide and radiotherapy
- C20: Vascularity in regions of highest choline predicts progression in low grade astrocytomas
- C21: Hormone replacement therapy use and incidence of central nervous system tumours: the Million Women Study
- C22: Outcome in a 2-year cohort of brain metastases patients treated in a specialist multi-disciplinary clinic at University College London Hospital
- C23: Space-time clustering of childhood CNS tumours in Yorkshire between 1974 - 2006
- C24: Histone deacetylase inhibition attenuates cellular growth in high grade paediatric brain tumours with associated telomerase inhibition and apoptotic induction.
- C25: An investigation of the functional role of RASSF1A in medulloblastoma
- C26: Tricyclic antidepressants protect against glioma and colorectal cancer
- C27: Determination of biological targeting of high grade glioma with BPA-Mannitol to facilitate Boron neutron capture therapy (BNCT)
